
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. VER MÁS
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS
Fecha de publicación: 2 abril de 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based...
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI